Stay updated on Intranasal Ketamine in Autism Social Impairment Clinical Trial
Sign up to get notified when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.

Latest updates to the Intranasal Ketamine in Autism Social Impairment Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays the completed clinical-trial record for intranasal ketamine in autism, including eligibility criteria, study design, and outcome measures, instead of a 403 error.SummaryDifference46%

- Check15 days agoChange DetectedThe footer now identifies the site as revision v3.8.0 rather than v3.7.2. The study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner was added announcing NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and linking to related updates and FAQs.SummaryDifference1%

- Check29 days agoChange DetectedThe footer's revision identifier changed from v3.7.1 to v3.7.2, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1; the 403 Forbidden page remains otherwise unchanged.SummaryDifference0.2%

- Check56 days agoChange DetectedA 403 Forbidden error content is displayed in place of the study record, signaling blocked access to the page. The visible structure remains, but the main content shows an error instead of the study details.SummaryDifference18%

Stay in the know with updates to Intranasal Ketamine in Autism Social Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intranasal Ketamine in Autism Social Impairment Clinical Trial page.